Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,420Revenue $M172Net Margin (%)9.7Z-Score27.2
Enterprise Value $M1,315EPS $0.6Operating Margin %15.5F-Score4
P/E(ttm))82.7Cash Flow Per Share $0.9Pre-tax Margin (%)15.2Higher ROA y-yN
Price/Book6.710-y EBITDA Growth Rate %15.5Quick Ratio5.5Cash flow > EarningsY
Price/Sales7.75-y EBITDA Growth Rate %8.8Current Ratio6.5Lower Leverage y-yY
Price/Cash Flow43.2y-y EBITDA Growth Rate %2.7ROA % (ttm)8.7Higher Current Ratio y-yN
Dividend Yield %0.7Insider Buy (3m)0ROE % (ttm)10.0Less Shares Outstanding y-yN
Payout Ratio %34.0Shares Outstanding M22.5ROI % (ttm)16.1Gross Margin Increase y-yN

Gurus Latest Trades with ABAX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABAXJoel Greenblatt 2014-12-31 Add0.05%$47.28 - $59.81
($53.8)
$ 60.9213%Add 680.44%124,964
ABAXJoel Greenblatt 2014-09-30 Reduce-0.01%$41.8 - $53.11
($47)
$ 60.9230%Reduce -39.12%16,012
ABAXJoel Greenblatt 2014-06-30 Add$37.95 - $44.61
($41.57)
$ 60.9246%Add 30.03%26,303
ABAXPRIMECAP Management 2014-03-31 Add0.06%$36.29 - $45.01
($39.69)
$ 60.9254%Add 244.23%1,979,300
ABAXJoel Greenblatt 2014-03-31 Reduce-0.01%$36.29 - $45.01
($39.69)
$ 60.9254%Reduce -21.35%20,229
ABAXPRIMECAP Management 2013-12-31 Buy 0.03%$32.4 - $41.25
($36.8)
$ 60.9266%New holding, 575000 sh.575,000
ABAXJoel Greenblatt 2013-12-31 Buy 0.02%$32.4 - $41.25
($36.8)
$ 60.9266%New holding, 25721 sh.25,721
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABAX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ABAX Joel Greenblatt 2014-12-31124,9640.550.06+680.44%
ABAX PRIMECAP Management 2014-12-312,022,2008.970.12+2.48%
Premium Most recent portfolio changes are included for Premium Members only!


ABAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SINGH PRITHIPALDirector 2015-02-09Sell2,500$60.53.19view
ARON KENNETHChief Technology Officer 2014-12-08Sell2,000$56.6810.14view
SEVERSON CLINTONPresident,CEO & Board Chairman 2014-11-25Sell2,286$5611.48view
SEVERSON CLINTONPresident,CEO & Board Chairman 2014-11-13Sell10,000$5513.51view
SEVERSON CLINTONPresident,CEO & Board Chairman 2014-11-05Sell10,000$5415.61view
INES ALBERTO SANTACFO and VP of Finance 2014-11-03Sell10,621$52.9517.9view
INES ALBERTO SANTACFO and VP of Finance 2014-11-03Sell1,652$53.0917.59view
SEVERSON CLINTONPresident,CEO & Board Chairman 2014-11-03Sell5,000$5317.79view
SEVERSON CLINTONPresident,CEO & Board Chairman 2014-10-31Sell10,000$51.521.22view
BASTIANI RICHARDDirector 2014-08-12Sell1,000$45.437.51view

Press Releases about ABAX :

    Quarterly/Annual Reports about ABAX:

    News about ABAX:

    Articles On GuruFocus.com
    ABAXIS Inc. (ABAX) COO Donald Peter Wood sells 6,460 Shares Mar 08 2011 
    ABAXIS Inc. (ABAX) President,CEO & Board Chairman Clinton Severson sells 35,000 Shares Dec 10 2010 
    ABAXIS Inc. (ABAX) President,CEO & Board Chairman Clinton Severson sells 96,000 Shares Dec 08 2010 
    ABAXIS Inc. (ABAX) President,CEO & Board Chairman Clinton Severson sells 66,029 Shares Dec 07 2010 
    ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd. Jan 13 2009 


    More From Other Websites
    Omnicare (OCR) Q4 Earnings, Sales Top Estimates; Rise Y/Y - Analyst Blog Mar 02 2015
    Globus Medical (GMED) Beats on Q4 Earnings, Sales in Line - Analyst Blog Mar 02 2015
    Allscripts (MDRX) Tops Q4 Earnings by a Penny, Revenues Lag - Analyst Blog Feb 27 2015
    Walgreens Boots: Market Optimism on Merger Makes It a Buy - Analyst Blog Feb 26 2015
    Medtronic's VenaSeal Wins FDA Nod for Vericose Veins Cure - Analyst Blog Feb 26 2015
    Fresenius Medical Care (FMS) Tops Q4 Earnings, Revenues - Analyst Blog Feb 26 2015
    Wright Medical Q4 Loss Narrower than Expected, Revenues Lag - Analyst Blog Feb 26 2015
    Are You Considering Abaxis (ABAX) Post Solid Q3 Earnings? - Analyst Blog Feb 25 2015
    Abaxis, Inc. to Present at the Raymond James 36th Annual Institutional Investors Conference Feb 25 2015
    Merit Medical (MMSI) Q4 Earnings, Sales Top Estimates; Up Y/Y - Analyst Blog Feb 25 2015
    Abaxis, Inc. to Present at the Raymond James 36th Annual Institutional Investors Conference Feb 25 2015
    Medtronic Adds Advanced Uro-Solutions to Neuromodulation - Analyst Blog Feb 24 2015
    ResMed Upped to Hold on Several Growth Initiatives - Analyst Blog Feb 24 2015
    What Makes Agios Pharmaceuticals (AGIO) a Strong Sell? - Tale of the Tape Feb 24 2015
    Medtronic's Artificial Pancreas Technology: Key to Diabetes Cure? - Analyst Blog Feb 23 2015
    Zimmer Upbeat on Biomet Takeover, Americas Sales Disappoint - Analyst Blog Feb 23 2015
    Bruker Beats Q4 Earnings by a Penny, Revenues Miss the Mark - Analyst Blog Feb 20 2015
    Boston Scientific Settles $7.2B J&J Suit for $600M, Stock Up - Analyst Blog Feb 19 2015
    Boston Scientific (BSX) Shows Strength: Stock Up 12.4% - Tale of the Tape Feb 19 2015
    Hanger to Amend and Reissue Financial Data; Results Delayed - Analyst Blog Feb 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK